Bart Geboers

22PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Photovoltaic power systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Mar 26, 2025
Systemic immunomodulation by irreversible electroporation versus stereotactic ablative body radiotherapy in locally advanced pancreatic cancer: the CROSSFIRE trial.

Bart Geboers, Florentine Timmer, Danielle Vos

|Aug 05, 2024
Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti-tumour T-cell activation - IRE-IMMUNO study.

Bart Geboers, Matthijs J Scheltema, Jason Jung

|Mar 28, 2024
The Added Value of Transcatheter CT Hepatic Angiography (CTHA) Image Guidance in Percutaneous Thermal Liver Ablation: An Experts' Opinion Pictorial Essay.

Robbert S Puijk, Madelon Dijkstra, Susan van der Lei

|Oct 20, 2023
Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.

Bart Geboers, Dennie Meijer, William Counter

|May 15, 2023
Transcatheter CT arteriography-guided irreversible electroporation of locally advanced pancreatic adenocarcinoma: A pictorial essay.

Bart Geboers, Susan van der Lei, Louiza Te Kloppenborg

|Jan 03, 2023
Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer.

Bart Geboers, Matthijs J Scheltema, Alexandar Blazevski

Pageof 4

Frequent Collaborators

13 joint publications

Martijn R Meijerink

9 joint publications

Robbert S Puijk

8 joint publications

Florentine Ef Timmer

8 joint publications

Madelon Dijkstra